Evidence map›Paper›PMID 27993177›Full record

Trial reportThe British journal of nutrition2016

Diets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk.

Nathalie Bergeron, Paul T Williams, Regina Lamendella, Nastaran Faghihnia, Alyssa Grube, Xinmin Li, Zeneng Wang, Rob Knight, Janet K Jansson, Stanley L Hazen and 1 more

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The British journal of nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04160481 (A Randomised, Double-blinded, Cross-over, Placebo- Controlled Pilot Study to Investigate the Effect of Tomato Extract on TMAO in Overweight or Obese Adults), which is not on this map. Cited by 49 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 4 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04160481 nacompletednot on this mapstarted 2019, after this paper: background citation

A Randomised, Double-blinded, Cross-over, Placebo- Controlled Pilot Study to Investigate the Effect of Tomato Extract on TMAO in Overweight or Obese Adults

TypeinterventionalSponsordsm-firmenich Switzerland AGRan2019 to 2020Enrolled37ConditionsCardiovascular Risk FactorArmsFruitFlow, Placebo
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 4 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. [Research progress in mechanisms of dietary resistant starch for regulating glucose and lipid metabolism].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Review
  14. Trimethylamine-Annals of medicine · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Nathalie Bergeron1Children's Hospital Oakland Research Institute,Oakland,CA 94609,USA.
Paul T Williams3Lawrence Berkeley National Laboratory,Department of Genome Sciences,Life Sciences Division,Berkeley,CA 94720,USA.
Regina Lamendella4Juniata College,Huntingdon,PA 16652,USA.
Nastaran Faghihnia1Children's Hospital Oakland Research Institute,Oakland,CA 94609,USA.
Alyssa Grube4Juniata College,Huntingdon,PA 16652,USA.
Xinmin Li5Department of Cellular & Molecular Medicine,Cleveland Clinic,Cleveland,OH 44195,USA.
Zeneng Wang5Department of Cellular & Molecular Medicine,Cleveland Clinic,Cleveland,OH 44195,USA.
Rob Knight6Departments of Pediatrics and Computer Science & Engineering,University of California San Diego,San Diego,CA 92093,USA.
Janet K Jansson8Pacific Northwest National Laboratory,Biological Sciences Division,Richland,WA 99352,USA.
Stanley L Hazen5Department of Cellular & Molecular Medicine,Cleveland Clinic,Cleveland,OH 44195,USA.
Ronald M Krauss1Children's Hospital Oakland Research Institute,Oakland,CA 94609,USA.
Cleveland Clinic · USJuniata College · USLawrence Berkeley National Laboratory · USPacific Northwest National Laboratory · USTouro University California · USUniversity of California, San Diego · US

Funding

Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Gut Flora Metabolism of Dietary Phosphatidylcholine and CVDR01HL103866 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI HAZEN, STANLEY L · 2010 to 2023
$10.8M
Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney DiseaseR01DK106000 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI HAZEN, STANLEY L, TANG, WAI HONG WILSON · 2015 to 2018
$2.8M
Effects of resistant starch on lipid and glucose metabolism in insulin resistanceRC1DK086472 · NIDDK · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI BERGERON, NATHALIE, KRAUSS, RONALD M · 2009 to 2010
$1000k
NCATS NIH HHS UL1 TR000004NHLBI NIH HHS R01 HL103866NIDDK NIH HHS R01 DK106000NIDDK NIH HHS RC1 DK086472
6 · The paper itself

Abstract

Production of trimethylamine-N-oxide (TMAO), a biomarker of CVD risk, is dependent on intestinal microbiota, but little is known of dietary conditions promoting changes in gut microbial communities. Resistant starches (RS) alter the human microbiota. We sought to determine whether diets varying in RS and carbohydrate (CHO) content affect plasma TMAO levels. We also assessed postprandial glucose and insulin responses and plasma lipid changes to diets high and low in RS. In a cross-over trial, fifty-two men and women consumed a 2-week baseline diet (41 percentage of energy (%E) CHO, 40 % fat, 19 % protein), followed by 2-week high- and low-RS diets separated by 2-week washouts. RS diets were assigned at random within the context of higher (51-53 %E) v. lower CHO (39-40 %E) intake. Measurements were obtained in the fasting state and, for glucose and insulin, during a meal test matching the composition of the assigned diet. With lower CHO intake, plasma TMAO, carnitine, betaine and γ-butyrobetaine concentrations were higher after the high- v. low-RS diet (P<0·01 each). These metabolites were not differentially affected by high v. low RS when CHO intake was high. Although the high-RS meal reduced postprandial insulin and glucose responses when CHO intake was low (P<0·01 each), RS did not affect fasting lipids, lipoproteins, glucose or insulin irrespective of dietary CHO content. In conclusion, a lower-CHO diet high in RS was associated with higher plasma TMAO levels. These findings, together with the absence of change in fasting lipids, suggest that short-term high-RS diets do not improve markers of cardiometabolic health.

Indexed as

Diet, Carbohydrate-RestrictedAdultBiomarkersBody Mass IndexCaliforniaCardiovascular DiseasesCross-Over StudiesDiet, Carbohydrate LoadingDysbiosisFemaleGastrointestinal MicrobiomeHumansHyperglycemiaHyperinsulinismInsulin ResistanceMaleBiomarkersMethylaminesStarchtrimethyloxamineCarbohydrateCVDGlucoseHOMA-IR homoeostatic model assessment of insulin resistanceInsulinLipidsResistant starchRS resistant starchesTMAO trimethylamine-N-oxideTrimethylamine-N-oxide

Identifiers

PMID27993177
PMCPMC5885763
OpenAlexW2561168692

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.